MitomycinAntineoplastic Combined Chemotherapy ProtocolsMitomycinsChemotherapy, AdjuvantCisplatinCombined Modality TherapyAntineoplastic AgentsAntibiotics, AntineoplasticDoxorubicinTreatment OutcomeCyclophosphamideNeoadjuvant TherapyDisease-Free SurvivalEtoposideBreast NeoplasmsSurvival AnalysisNeoplasm StagingLung NeoplasmsDrug Administration ScheduleSurvival RatePrognosisVinblastineMethotrexateNucleic Acid Synthesis InhibitorsPorfiromycinCarboplatinIfosfamidePaclitaxelBleomycinNeoplasm Recurrence, LocalDrug Resistance, NeoplasmTaxoidsInduction ChemotherapyChemotherapy, Cancer, Regional PerfusionAntimetabolites, AntineoplasticDeoxycytidineAlkylating AgentsNeoplasmsOrganoplatinum CompoundsDicumarolFollow-Up StudiesVindesineCarcinoma, Non-Small-Cell LungAdenocarcinomaAntineoplastic Agents, AlkylatingTime FactorsPterygiumNeoplasm MetastasisAnthracyclinesVomitingDose-Response Relationship, DrugCytarabineTrabeculectomyInfusions, Intra-ArterialSalvage TherapyNeutropeniaLeukopeniaAntineoplastic Agents, PhytogenicNauseaTransplantation, AutologousRadiotherapy, AdjuvantOvarian NeoplasmsStomach NeoplasmsProspective StudiesTesticular NeoplasmsColorectal NeoplasmsHyperthermia, InducedCarmustineLymphoma, Non-HodgkinCamptothecinHodgkin DiseaseClinical Trials as TopicPeritoneal NeoplasmsLiver NeoplasmsRadiotherapyInfusions, IntravenousRecurrenceMitoxantroneTegafurCarcinoma, Squamous CellCell Line, TumorDacarbazineMelphalanAziridinesNeoplasms, Germ Cell and EmbryonalFanconi AnemiaLomustineGranulocyte Colony-Stimulating FactorKaplan-Meier EstimatePlatinum CompoundsBrain NeoplasmsBone NeoplasmsDaunorubicinNAD(P)H Dehydrogenase (Quinone)Cell SurvivalCarcinomaOsteosarcomaDNA DamageAntiemeticsRadiotherapy Dosage